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The International Atomic Energy Agency (IAEA) developed a comprehensive program—Quality
Management Audits in Nuclear Medicine (QUANUM). This program covers all aspects of nuclear
medicine practices including, but not limited to, clinical practice, management, operations, and
services. The QUANUM program, which includes quality standards detailed in relevant check-
lists, aims at introducing a culture of comprehensive quality audit processes that are patient oriented,
systematic, and outcome based. This paper will focus on the impact of the implementation of
QUANUM on daily routine practices in audited centers. Thirty-seven centers, which had been
externally audited by experts under IAEA auspices at least 1 year earlier, were invited to run an
internal audit using the QUANUM checklists. The external audits also served as training in quality
management and the use of QUANUM for the local teams, which were responsible of conduct-
ing the internal audits. Twenty-five out of the 37 centers provided their internal audit report, which
was compared with the previous external audit. The program requires that auditors score each
requirement within the QUANUM checklists on a scale of 0-4, where 0-2 means nonconfor-
mance and 3-4means conformance to international regulations and standards onwhichQUANUM
is based. Our analysis covering both general and clinical areas assessed changes on the con-
formance status on a binary manner and the level of conformance scores. Statistical analysis was
performed using nonparametric statistical tests. The evaluation of the general checklists showed
a global improvement on both the status and the levels of conformances (P < 0.01). The evalua-
tion of the requirements by checklist also showed a significant improvement in all, with the exception
of Hormones and Tumor marker determinations, where changes were not significant. Of the 25
evaluated institutions, 88% (22 of 25) and 92% (23 of 25) improved their status and levels of con-
formance, respectively. Fifty-five requirements, on average, increased from nonconformance to
conformance status. In 8 key areas, the number of improved requirements was well above the
average: Administration &Management (checklist 2); Radiation Protection & Safety (checklist 4);
General Quality Assurance system (checklist 6); Imaging Equipment Quality Assurance or Quality
Control (checklist 7); General Diagnostic (checklist 9); General Therapeutic (checklist 12);
Radiopharmacy Level 1 (checklist 14); and Radiopharmacy Level 2 (checklist 15). Analysis of results
related to clinical activities showed an overall positive impact on both the status and the level of
conformance to international standards. Similar results were obtained for the most frequently per-
formed clinical imaging and therapeutic procedures. Our study shows that the implementation
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of a comprehensive quality management system through the IAEAQUANUMprogram has a posi-
tive impact on nuclear medicine practices.
Semin Nucl Med 48:299–306 © 2018 The Authors. Published by Elsevier Inc. This is an open
access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
In the last decades, the importance of providing the bestpossible medical services as well as the need for standard-
ization has been increasingly recognized among health-care
providers and patients.1,2
The International Atomic Energy Agency (IAEA) is a member
of the United Nations system with the mission of fostering
peaceful applications of nuclear techniques in several fields,
including human health.3 Through its Human Health Division,4
the IAEA has developed a program on Quality Management
Audits in Nuclear Medicine Practices (QUANUM),5,6 to help
its member states verify the status of their nuclear medicine
practices and their adherence to international reference
standards.7-25
The QUANUM program has been described in detail.26 In
summary, the program aims at promoting a culture of con-
tinuous improvement of quality management aspects of nuclear
medicine practice as a whole, including thorough training on
this matter, through implementation of internally managed
self-audits. Unlike other approaches to quality improve-
ment, the QUANUM program includes detailed checklists,
very specific to nuclear medicine and covering all aspects of
its practice, including clinical applications, radiopharmacy,
general and radiation safety, and quality assurance (QA) or
quality control (QC) of instruments. They also establish the
minimal requirements to be conformant to internationally rec-
ognized quality standards for the covered areas. Before
implementing any external audit, centers are requested to self-
assess their practices by completing the checklists, and then
a qualified team of external auditors is fielded to conduct an
independent confirmatory audit working in close contact with
local counterparts. External auditors will independently score
each requirement of applicable checklists and at the end of
the mission; the team provides recommendations that are dis-
cussed with local counterparts during the exit briefing. Based
on those recommendations, an action plan including correc-
tive actions and their implementation are agreed upon.
The rationale of the QUANUM program is based on the
assumption that meeting the recommendations set out by the
team of auditors and implementing the corrective actions
defined during the first external audits would help the audited
centers meet international quality standards and contribute
to enhancing their clinical practice. Results and findings from
a first batch of external audits have been published.27
However, to claim that a program of this kind is effective
requires proving that its application has a positive impact on
the audited centers. To this purpose, nuclear medicine centers
that underwent an external audit through the QUANUM
program for the first time at least 1 year before were re-
quested to conduct an internal follow-up audit and provide
results of this new self-assessment.
The current study aims at evaluating the impact of
QUANUM implementation on the quality of nuclear medi-
cine services based on change in adherence to previously set
reference standards.
Materials and Methods
At the time of the beginning of this study, 37 centers quali-
fied for re-evaluation. Those centers were invited to run an
internal follow-up internal audit, which is a fundamental part
of the QUANUM process. Twenty-five centers (67%) replied
and provided their new self-assessment. Figure 1 represents
their worldwide distribution.
Both internal and external audits are based on the QUANUM
program checklists,28 which require that, according to the level
of implementation, each requirement is scored from 0 (absent)
up to 4 (full conformance) or reported as not applicable. Scores
0, 1, and 2 of applicable items are considered nonconfor-
mance, whereas scores 3 and 4 are considered conformance.
As explained elsewhere,27,28 the overall results are graphi-
cally presented as radar plots built on the conformance level
reached for each area. It should be noted that results related
to general checklists (from 1 to 9, 12, and from 14 to 17)
are presented independently from those related to clinical prac-
tice (from 10.1 to 10.5, from 11.1 to 11.3, and from 13.1
to 13.3).
For the outcome assessment, we compared how the nuclear
medicine services met the QUANUM requirements during
the follow-up audit with the results of the first mission, after
addressing recommendations and implementing corrective
actions. For each requirement, the pair of answers recorded
from the first and follow-up audits were carefully checked
and validated before comparison. For instance, require-
ments, which in the initial audit were graded as not applicable
but became applicable in the follow-up self-assessment, or
the other way around, were not considered. Eventually, the
total number of validated pairs of requirements amounted
to 6915, of which 4990 belonged to checklists 1-9, 12, and
14-17, covering general components (administration; poli-
cies; safety and radioprotection; physics, including aspects
of dosimetry and quality assurance of equipment;
radiopharmacy, including management, training, proce-
dures, quality assurance; etc) whereas the remaining 1925
belonged to checklists 10.1-10.5, 11.1-11.3, and 13.1-
13.3, covering the clinical components, including overall
supervision of patient management and of all technical and
QA aspects,29,30 and a significant focus on standardization
and quality of the final report.
This analysis was carried out on the 25 surveyed centers,
focusing on 2 parameters:
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• changes of the Status of conformance, to verify how many
requirements, previously classified as nonconformance, were
up-scored to conformance, or vice versa. It was expected
that most of the registered changes were in a positive di-
rection from nonconformance to conformance.
• changes of Level of conformance of each requirement, that
is, their ranking, as indicated by the overall scores reached
using the previously described grading system 0-4.3,4 This
approach allows detecting any improvement or worsen-
ing of the quality systems even within the same conformance
status. It was expected that it would change toward higher
scores.
The implementation of the action plan defined at the end
of the initial external audit was expected to increase not only
the number of conformances but also their levels.
Statistical Analysis
Nonparametric statistical tests were used to assess changes
in the status and levels of conformance of the requirements
set out by the QUANUM program. This choice of test was
based on the nature of the available data. The status of con-
formances was recorded on a dichotomous variable and the
levels of conformance in ordinal values from 0 to 4. More-
over, some of the evaluated samples had a reduced size. Taking
into account that the compared sets of data were collected
from the same services at 2 different moments, they were con-
sidered paired or repeated observations. Therefore, the
McNemar and the Wilcoxon signed rank tests were used for
the statistical analysis of the changes in the status and levels
of conformances, respectively.
The Wilcoxon signed rank test allowed considering
the magnitude of the level of conformance changes for the
evaluated pairs of requirements. Differences between the
first and the follow-up audits were based on the following
criteria: not significant if P > 0.05, significant if P < 0.05,
and very significant if P < 0.01. For the analysis of results,
the number of positive and negative changes, number of
ties, number of ranks, and rank sums were used as comple-
mentary data. Two-tailed tests and 1-tailed tests were used
according to the required data analysis for the evaluated
hypothesis. Statistical analysis was performed using SPSS
Statistics for Windows, version 22.0, released 2013 (IBM
Corp, Armonk, NY).
For both general and clinical checklists, the overall evalu-
ation covers the whole sample, where changes in all validated
pairs of requirements are considered. This is followed by a
stratification of the analysis at the level of institutions and for
each independent checklist. Finally, to verify the impact of
the program on clinical practice, samples of routine clinical
studies are checked and a comparison of their level of con-
formance to international standards and regulations is also
carried out.
Figure 1 Worldwide distribution of audited centers (country level). Numbers are related to the number of audited centers within each country.
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Results
Our analysis compares the validated pairs of results and their
differences, if any, between the results of the follow-up audit
run by teams of internal auditors and those from the first audit
run by the teams of external auditors. For the purpose of our
study, an analysis of general checklists was carried out at global
and specific levels, as well as a specific analysis of clinical
procedures.
Global Analysis of General Checklists
This analysis covers the requirements from the 14 general
checklists collected from the 25 re-assessed institutions and
is based on the global analysis of the changes of each pair
of results. The average total score expressed as a percentage
of the maximum achievable score improved from 73.2% to
83.2% (P < 0.01), as visually reflected by an increase of the
area inside the radar plots built from the full statistic of the
audit results3 shown in Figure 2.
Adherence to the international standards taken as refer-
ence from the QUANUM program,4 and shown by the status
of conformance, shows that out of the 4990 validated pairs
of requirements, a total of 879 (17.6%) modified their con-
formance status. An overall very significant improvement in
the status of conformance between the external and the in-
ternal follow-up audits (P < 0.01) was detected. Indeed, out
of those 879 cases, which modified their status of confor-
mance, in 770 (86%) there is an upstage from nonconformance
to conformance, whereas the remaining 109 changes (12%)
are in a negative direction, from conformance to nonconfor-
mance (Figure 3). The remaining 4111 requirements were ties,
that is, did not show any modification. An overall very sig-
nificant improvement in the status of conformance between
the external and the internal follow-up audits (P < 0.01) was
detected.
Specific Analysis of General Checklists
To assess which areas are more significantly affected by the
QUANUM program, a detailed evaluation of general check-
list was also carried out, with key areas 1-9, 12, 14, and 15
showing very significant improvements (P < 0.01) in their Level
of conformance, as reflected by the score obtained, whereas
checklist 16 (radiopharmacy level III) showed a significant
improvement (P < 0.05). Only checklist 17, related to Hor-
mones and Tumor markers determinations, did not show any
significant change (P = 0.816).
As regards the changes of the Status of conformance, key
areas 1-9, 12, and 14-16 present a significantly (P < 0.05) or
very significantly (P < 0.01) higher number of confor-
mances in the follow-up audit. As for the level of conformance,
checklist 17, related to Hormones and Tumor markers, also
showed a no significant difference (P = 0.188) between the
Figure 2 Radar plots computed from 25 institutions showing the general improvement on key areas from the first to the follow-up audit.
Figure 3 Global number of positive and negative changes of the status
of conformance, for requirements of checklists 1-9, 12, and 14-17.
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2 audits. Figure 4 shows the magnitude of changes, both posi-
tive and negative, of the conformance status for checklists 1-9,
12, and 14-17. The number of positive changes ranged from
as low as 7, for checklist 17 (Hormones and Tumor markers),
and up to a maximum of 89 for checklist 15 (Radiopharmacy
Level 2). The mean number of changes is 55, with 8 key areas
above this value, namely Administration & Management
(checklist 2); Radiation Protection & Safety (checklist 4);
General QA system (checklist 6); Imaging Equipment QA or
QC (checklist 7); General Diagnostic (checklist 9); General
Therapeutic (checklist 12); Radiopharmacy Level 1 (check-
list 14); and Radiopharmacy Level 2 (checklist 15).
Based on the changes in conformance levels in the 25 sur-
veyed institutions, our study shows a very significant
improvement (P < 0.01) in 23 (92%) between the 2 audits,
together with a prevalence toward higher values. Only 2 in-
stitutions (number 6 and 22) maintained a similar performance
without any significant difference (P > 0.05), (Fig. 5), with
virtually no changes for institution 22 and a comparable
number of positive and negative changes for institution 6.
Figure 4 Changes of the conformance status for specific activity fields as reflected by checklists. Checklist 1: Strate-
gies; Checklist 2: Administration & Management; Checklist 3: Human Resources; Checklist 4: Radiation Protection
& Safety; Checklist 5: Patient Radiation Protection; Checklist 6: General QA system; Checklist 7: Imaging Equip-
ment QA/QC; Checklist 8: IT Systems; Checklist 9: General Diagnostic; Checklist 12: General Therapeutic; Checklist
14: Radiopharmacy Level 1; Checklist 15: Radiopharmacy Level 2: Checklist 16: Radiopharmacy Level 3; and Check-
list 17: Hormones and Tumor markers (H&T).
Figure 5 Magnitude of level of conformance changes between the first and the follow-up audits by institution as re-
flected by the sum of ranks.
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Specific Analysis of Clinical Checklists
(10.1-10.5; 11.1-11.3; 13.1-13.3)
Adherence of clinical practice to international standards was
assessed, collecting detailed information on 5 randomly se-
lected clinical procedures through specific checklists for a total
of 1925 requirements. In comparison with baseline audits,
change of conformance status was found in 131 cases. Out
of those, 110 (83.9%) changed from nonconformance to con-
formance (Fig. 6A). These results reflected a very significant
improvement (P < 0.01).
The evaluation of the changes of the conformance levels
was also carried out on clinical checklists. Figure 6B shows
an increase of the level of conformance in 269 items (posi-
tive changes) and a decrease in 125 (negative changes).
Statistically, the improvement is also very significant (P < 0.01).
The impact of the implementation of the QUANUM
program on clinical practices by field of activity, that is,
imaging, nonimaging, and therapy, was also analyzed. A very
significant (P < 0.01) improvement of the conformance status
was found for the imaging and therapy fields (Fig. 7), whereas
no significant modifications could be observed in the
nonimaging field (P = 0.125).
During both the external and the follow-up audits, clini-
cal practice is assessed by evaluating different types of
diagnostic studies or therapeutic procedures, up to 5, in ran-
domly selected patient files. For the present study, reports
covered a total number of 20 different types of procedures.
A significant improvement (P < 0.05) was detected for the more
frequently performed diagnostic modalities, such as bone scans,
renal dynamic studies, myocardial perfusion imaging, thyroid
scans, and for treatment of both hyperthyroidism and thyroid
cancer (Fig. 8).
Discussion
This work presents a quantitative assessment of the out-
comes of the systematic application of an IAEA comprehensive
program of quality assurance in nuclear medicine called
QUANUM. This evaluation is based on 2 parameters: (1)
change of the Status of conformance or nonconformance of
each requirement to previously set standards, and (2) the rela-
tive change in the score used to grade the Level of conformance.
Indeed the 2 parameters are strictly connected, as there cannot
be improvement in status of conformance without improve-
ment in the level of conformance (ie, its score). However, there
might be an increase of the conformance level from 0 to 2,
for example, which is still considered nonconformance despite
the improvement. Therefore, assessing changes in the level
of conformance provides a more detailed vision.
Overall we have seen a very significant improvement in both
the levels and the status of conformance for the general check-
lists as shown in Figures 2 and 3. In our opinion, this is
evidence that through the QUANUM program the auditors
efficiently identified the main areas of weakness and that the
corrective action plans that were agreed upon at the end of
the audits were effectively implemented with very positive
impact on many key areas.
The highest impact of the implementation of action plans
is found in the field of radiopharmacy services, both levels
1 and 2, which had the lowest conformance levels during the
initial external audit. This could be considered as a contri-
bution of the QUANUM to a worldwide ongoing process of
rising of the standards of quality in the production and use
of radiopharmaceuticals, following the full recognition of these
Figure 6 Changes of the conformance status (A) and of confor-
mance levels (B) in clinical checklists.
Figure 7 Number of positive and negative changes regarding the status
of conformance by field of activities in the clinical areas.
Figure 8 Types of studies showing a significant change in the con-
formance status. Hyper-Thy, treatment of benign thyroid conditions;
MPI, myocardial perfusion imaging; RD, renal dynamic; Thy-Cancer-
Tx, treatment of thyroid cancer; Thy-Scan, thyroid scanning; WBS,
whole-body scan.
304 M. Dondi et al.
products as pharmaceuticals in several countries or interna-
tional regulatory agencies.
The area of radiation protection and safety (checklist 4) also
showed a sharp increase on the status of conformance at
follow-up that is particularly relevant considering the im-
portance of radiation protection issues for staff, patients, and
public. Furthermore, radiation safety aspects are heavily regu-
lated by national and international regulatory agencies, and
compliance to the principles of optimization and practical
implementation of the ALARA, that is, as low as reasonably
possible, methodology, is mandatory.31-34 In audited centers,
the QUANUM has triggered a process of improvement and
better application of already existing safety standards, making
the working place safer for the staff and procedures safer for
patients.
Other key areas such as general aspects of clinical imaging
and therapeutic procedures, administration and manage-
ment, as well as quality management systems implementation
and QA or QC of imaging equipment showed significant
improvements well above the mean number of positive
changes, as shown in Figure 4. Some of these key areas
have already been reported28 as showing major deficiencies
and as sources of many recommendations related to lack of
standard operating procedures, structured records of QA or
QC, and evidence of traceability of the whole quality man-
agement system. These findings emphasize the importance
of preparing and maintaining an appropriate documenta-
tion system as a way to comply with international reference
standards.
Almost all surveyed institutions improved their adher-
ence to reference standards as shown by the increased number
of conformances (Figure 4).
As concerns overall results on clinical practice, we have
also found global improvements in both status and level of
conformance related to the different types of audited proce-
dures. When those procedures were grouped into 3 main fields
of activities, namely, (1) imaging, (2) nonimaging, and (3)
therapy (Figure 7), it was seen that imaging and therapy
showed a significant improvement, whereas nonimaging pro-
cedures did not show a significant change, most likely because
such procedures, except for sentinel node localization with
probes, are rarely performed nowadays, and the size of the
collected sample was too small.
Further detailed analysis of diagnostic (1) and therapeu-
tic (3) procedures showed a significant improvement for the
most commonly performed modalities (Fig. 8), whereas less
frequently performed procedures showed no significant change,
related with limited sample size.
The comment above, however, does not apply to posi-
tron emission tomography studies where no significant changes
were revealed at the follow-up audit despite an adequate
sample size. This finding might well be linked to the higher
awareness of the need of a good quality management system
in place when introducing complex and costly installations
such as positron emission tomography-computed tomogra-
phy and especially cyclotrons with their corresponding
radiopharmacy laboratories. For this reason, the initial audit
already showed high conformance levels.
Conclusions
The QUANUM program is the first example of a global ap-
proach to the implementation of quality management into the
daily practice of nuclear medicine, with extensive coverage
of the clinical aspects and related components of medical
physics and radiopharmacy. To the best of our knowledge,
there are no data published on such an experimental ap-
proach, and in many cases the outcomes of Quality
Management Systems implementation are assumed or ex-
pected, but not directly observed and measured.
The present outcome-based study confirms the useful-
ness of the QUANUM program as a practical tool to implement
a quality management system and raise the conformance to
international guidelines, regulations, and standards, by imple-
menting the recommendations given by experts at the end
of the external audits.
These results speak in favor of introducing regular quality
audit programs, including both internal and external peri-
odic assessments, to improve adherence to national and
international standards of quality, improving the quality of
nuclear medicine practice and consequently meeting the re-
quirements of accreditation bodies, regulatory authorities, and
patient advocate organizations, therefore.
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